Research and Development

BioMarin confirms layoffs and R&D cuts

By LabPulse.com staff writers

Roctavian, BioMarin's gene therapy for severe hemophilia A, generated $800,000 in net product revenue in the first quarter of 2024.

May 15, 2024

Danaher launches collaboration with Johns Hopkins University on TBI diagnostics

By LabPulse.com staff writers

Danaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.

May 9, 2024

Novo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challenges

By LabPulse.com staff writers

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.

May 6, 2024

Astellas and Poseida to collaborate on oncology cell therapies

By LabPulse.com staff writers

Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.

May 2, 2024

GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials

By LabPulse.com staff writers

Genomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.

May 1, 2024

Immunovia announces positive results for next-gen pancreatic cancer test

By LabPulse.com staff writers

Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.

April 25, 2024

Ipsen, Skyhawk to collaborate on drug discovery for rare neurological disorders

By LabPulse.com staff writers

Biopharmaceutical company Ipsen and clinical-stage biopharmaceutical firm Skyhawk have signed an exclusive collaboration to discover and develop small-molecule therapeutics targeting RNA to treat rare neurological disorders.

April 22, 2024

Fujifilm Diosynth Biotechnologies confirms layoffs

By LabPulse.com staff writers

Fujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.

April 19, 2024

Quest and Broad partner for infant whole genome sequencing research

By LabPulse.com staff writers

Quest Diagnostics and Broad Clinical Labs have announced a research collaboration exploring whole genome sequencing (WGS) on infants as a first-line genetic test for diagnosis of developmental delay disorders.

April 3, 2024

Castle Biosciences shares melanoma test study data at SSO 2024

By LabPulse.com staff writers

Castle Biosciences shared data from two studies on the performance of its DecisionDx-Melanoma test in patients with cutaneous melanoma at the Society of Surgical Oncology 2024 (SSO 2024) annual meeting, held March 20-23 in Atlanta.

March 26, 2024

ChromaCode partners with the Medical College of Georgia on NSCLC assay validation

By LabPulse.com staff writers

ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.

March 21, 2024

International consortium launches project to develop next generation of vaccines

By Matt Limb

An international consortium of researchers specializing in human challenge studies is embarking on a $57 million project to develop advanced virus-blocking coronavirus vaccines.

March 15, 2024

Page 1 of 39

Next Page